Phenolics in Aging and Neurodegenerative Disorders

Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology

Volumn , Issue , 2009, Pages 427-451

  Calabrese, Vittorio ^a   Perluigi, Marzia ^b   Cornelius, Carolin ^a   Coccia, Raffaella ^b   Di Domenico, Fabio ^b   Pennisi, Giovanni ^a   Cini, Chiara ^b   Dinkova Kostova, Albena T ^c,d  

^a UNIVERSITY OF CATANIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neurodegeneration and lipid oxidation isoprostanes; Phenolics in aging and neurodegenerative disorders; Redox regulation metabolic modulator of cellular functions in chronic diseases

Indexed keywords

EID: 84889624116     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470531792.ch18     Document Type: Chapter

References (124)

1. Andersen JK. 2004. Oxidative stress in neurodegeneration: Cause or consequence? Nat Med 10 Suppl:S18-S25.
2. Anzai K, Ogawa K, Goto Y, Senzaki Y, Ozawa T, Yamamoto H. 1999. Oxidationdependent changes in the stability and permeability of lipid bilayers. Antioxid Redox Signal 1:339-347.
3. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, Kocak A, Yologlu S. 2007. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 294:137-144.
4. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA. 2008. Curcumin structure-function, bioavailablity and efficacy in models of neuroinflammation and Alzheimer's. J Pharmacol Exp Ther, in press.
5. Berlett BS, Stadtman ER. 1997. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313-20316.
6. Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK. 2002. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 64:1037-1048.
7. Biswas S, Rahman I. 2008. Modulation of steroid activity in chronic inflammation: A novel anti-inflammatory role for curcumin. Mol Nutr Food Res 52:987-994.
8. Bolton RM, Ahokas JT. 1997. Purification and characterization of hepatic glutathione transferases from an insectivorous marsupial, the brown antechinus (Antechinus stuartii). Xenobiotica 27:573-586.
9. Borges CR, Geddes T, Watson JT, Kuhn DM. 2002. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 277:48295-48302.
10. Butterfield DA, Sultana R. 2007. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment:Insights into the progression of this dementing disorder. J Alzheimers Dis 12:61-72.
11. Butterfield DA, Abdul HM, Newman S, Reed T. 2006a. Redox proteomics in some agerelated neurodegenerative disorders or models thereof. NeuroRx 3:344-357.
12. Butterfield DA, Perluigi M, Sultana R. 2006b. Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics. Eur J Pharmacol 545:39-50.
13. Calabrese EJ. 2008a. Hormesis: Why it is important to toxicology and toxicologists. Environ Toxicol Chem 27:1451-1474.
14. Calabrese EJ. 2008b. Pharmacological enhancement of neuronal survival. Crit Rev Toxicol 38:349-389.
15. Calabrese V. 2007. Highlight commentary on ''Redox proteomics analysis of oxidatively 3 modified proteins in G93A-SOD1 transgenic mice-A model of 4 familial amyotrophic lateral sclerosis.'' Free Radical Biol Med 43:160-162.
16. Calabrese EJ, Baldwin LA. 1998. Hormesis as a biological hypothesis. Environ Health Perspect 106:357-362.
17. Calabrese V, Maines MD. 2006. Antiaging medicine: Antioxidants and aging. Antioxid Redox Signal 8:362-364.
18. Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C, Butterfield DA, Stella AG. 2007a. Redox regulation of cellular stress response in aging and neurodegenerative disorders: Role of vitagenes. Neurochem Res 32:757-773.
19. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Giuffrida Stella AM. 2007b. Nitric oxide in the CNS: Neuroprotection versus neurotoxicity. Nat Neurosci 8:766-775.
20. Calabrese V, Mancuso C, Sapienza M, Puleo E, Calafato S, Cornelius C, Finocchiaro M, Mangiameli A, Di Mauro M, Stella AM, Castellino P. 2007c. Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12:299-306.
21. Calabrese V, Colombrita C, Scapagnini G, Calvani M, Giuffrida Stella AM. Butterfield DA. 2006a. Acetylcarnitine and cellular stress response: Role in nutritional redox homeostasis and regulation of longevity genes. J Nutr Biochem 17:73-88.
22. Calabrese V, Butterfield DA, Scapagnini G, Stella AM, Maines MD. 2006b. Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: Relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid Redox Signal 8:444-477.
23. Calabrese V, Colombrita C, Sultana R, Scapagnini G, Calvani M, Butterfield DA, Stella AM. 2006c. Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: Relationship to antioxidant status and mitochondrial function. Antioxid Redox Signal 8:404-416.
24. Calabrese V, Calvani M, Butterfield DA. 2006d. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. J Neurosci Res 84:398-408.
25. Calabrese V, Ravagna A, Colombrita C, Guagliano E, Scapagnini G, Calvani M, Butterfield DA, Giuffrida Stella AM. 2005. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: Involvement of the transcription factor Nrf2. J Neurosci Res 79:509-521.
26. Calabrese V, Scapagnini G, Giuffrida Stella AM, Bates TE, Clark JB. 2001. Mitochondrial involvement in brain function and dysfunction: Relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 26:739-764.
27. Chakravarti B, Chakravarti DN. 2007. Oxidative modification of proteins: Age-related changes. Gerontology 53:128-139.
28. Chang TS, Jeong W, Woo HA, Lee SM, Park S, Rhee SG. 2004. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem 279:50994-51001.
29. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. 2008. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett 259:111-118.
30. Chrestensen CA, Starke DW, Mieyal JJ. 2000. Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis. J Biol Chem 275:26556-26565.
31. Christen Y. 2000. Oxidative stress and Alzheimer disease. Am J Clin Nutr 71:621S-629S.
32. Clifford MN, Wu W, Kirkpatrick J, Kuhnert N. 2007. Profiling the chlorogenic acids and other caffeic acid derivatives of herbal chrysanthemum by LC-MSn. J Agric Food Chem 55:929-936.
33. Cohen G, Farooqui R, Kesler N. 1997. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 94:4890-4894.
34. Cotgreave IA, Gerdes RG. 1998. Recent trends in glutathione biochemistry-glutathione-protein interactions: A molecular link between oxidative stress and cell proliferation? Biochem Biophys Res Commun 242:1-9.
35. Cudkowicz ME, Sexton PM, Ellis T, Hayden DL, Gwilt PR, Whalen J, Brown RH, Jr. 1999. The pharmacokinetics and pharmaco-dynamics of Procysteine in amyotrophic lateral sclerosis. Neurology 52:1492-1494.
36. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A. 2007. S-glutathionylation in protein redox regulation. Free Radic Biol Med 43:883-898.
37. Dalle-Donne I, Milzani A, Giustarini D, Di Simplicio P, Colombo R, Rossi R. 2000. SNO-actin: S-nitrosylation kinetics and the effect on isolated vascular smooth muscle. J Muscle Res Cell Motil 21:171-181.
38. Das KC. 2005. Thioredoxin and its role in premature newborn biology. Antioxid Redox Signal 7:1740-1743.
39. Dinkova-Kostova AT. 2002. Protection against cancer by plant phenylpropenoids:Induction of mammalian anticarcinogenic enzymes. Mini Rev Med Chem 2:595-610.
40. Dinkova-Kostova AT, Talalay. 2008. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52:S128-S138.
41. Dinkova-Kostova AT, Talalay P. 1999. Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20:911-914.
42. Dinkova-Kostova AT, Holtzclaw WD, Kensler TW. 2005. The role of Keap1 in cellular protective responses. Chem Res Toxicol 18:1779-1791.
43. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99:11908-11913.
44. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. 2001. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98:3404-3409.
45. Dinkova-Kostova AT, Abeygunawardana C, Talalay P. 1998. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: Correlation of potencies as phase 2 enzyme inducers and radical scavengers. J Med Chem 41:5287-5296.
46. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
47. Esterbauer H, Schaur RJ, Zollner H 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128.
48. Gallogly MM, Mieyal JJ. 2007. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7:381-391.
49. Ghezzi P, Bonetto V, Fratelli M. 2005. Thiol-disulfide balance: From the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 7:964-972.
50. Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic Biol Med 32:1264-1275.
51. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, Rossi R. 2006. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J Gerontol A Biol Sci Med Sci 61:1030-1038.
52. Giustarini D, Milzani A, Aldini G, Carini M, Rossi R, Dalle-Donne I. 2005. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxid Redox Signal 7:930-939.
53. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. 2004. S-glutathionylation:From redox regulation of protein functions to human diseases. J Cell Mol Med 8:201-212.
54. Greco A, Minghetti L, Levi G. 2000. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem Res 25:1357-1364.
55. Halliwell B. 1999. Establishing the significance and optimal intake of dietary antioxidants:The biomarker concept. Nutr Rev 57:104-113.
56. Ishige K, Schubert D, Sagara Y. 2001. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433-446.
57. Janaky R, Ogita K, Pasqualotto BA, Bains JS, Oja SS, Yoneda Y, Shaw CA. 1999. Glutathione and signal transduction in the mammalian CNS. J Neurochem 73:889-902.
58. Johansson C, Lillig CH, Holmgren A. 2004. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 279:7537-7543.
59. Joshi G, Perluigi M, Sultana R, Agrippino R, Calabrese V, Butterfield DA. 2006. In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): Insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem Int 48:318-327.
60. Kalfon L, Youdim MB, Mandel SA. 2007. Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C-and proteasome-mediated degradation of Bad: Implications for neuroprotection. J Neurochem 100:992-1002.
61. Kannan R, Mittur A, Bao Y, Tsuruo T, Kaplowitz N. 1999. GSH transport in immortalized mouse brain endothelial cells: Evidence for apical localization of a sodium-dependent GSH transporter. J Neurochem 73:390-399.
62. Kanski J, Aksenova M, Stoyanova A, Butterfield DA. 2002. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure-activity studies. J Nutr Biochem 13:273-281.
63. Kikuzaki H, Hisamoto M, Hirose K, Akiyama K, Taniguchi H. 2002. Antioxidant properties of ferulic acid and its related compounds. J Agric Food Chem 50:2161-2168.
64. Klatt P, Lamas S. 2000. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267:4928-4944.
65. Klatt P, Molina EP, De Lacoba MG, Padilla CA, Martinez-Galesteo E, Barcena JA, Lamas S. 1999. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation.FASEB J 13:1481-1490.
66. Kregel KC, Zhang HJ. 2007. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292:R18-R36.
67. Leonardi ET, Mytilineou C. 1998. Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease. Adv Exp Med Biol 446:203-222.
68. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370-8377.
69. Lovell MA, Markesbery WR. 2007. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 35:7497-7504.
70. Mancuso C, Capone C, Ranieri SC, Fusco S, Calabrese V, Eboli ML. Preziosi P, Galeotti T, Pani G. 2008. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res 86:1212-1230.
71. Mancuso C, Bates TE, Butterfield DA, Calafato S, Cornelius C, De Lorenzo A, Dinkova Kostova AT, Calabrese V. 2007. Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drug 16:1921-1931.
72. Mandel S, Youdim MB. 2004. Catechin polyphenols: Neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37:304-317.
73. Mandel S, Amit T, Reznichenko L, Weinreb O, Youdim MB. 2006a. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res 50:229-234.
74. Mandel S, Weinreb O, Reznichenko L, Kalfon L, Amit T. 2006b. Green tea catechins as brain-permeable, non toxic iron chelators to ''iron out iron'' from the brain. J Neural Transm Suppl: 249-257.
75. Mann M, Jensen ON. 2003. Proteomic analysis of post-translational modifications. Nat Biotechnol 21:255-261.
76. Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. 2005. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58:730-735.
77. Martinez M, Ferrandiz ML, Diez A, Miquel J. 1995. Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice. Mech Ageing Dev 84:77-81.
78. Mattson MP. 2008. Hormesis defined. Ageing Res Rev 7:1-7.
79. Maybodi L, Pow DV, Kharazia VN, Weinberg RJ. 1999. Immunocytochemical demonstration of reduced glutathione in neurons of rat forebrain. Brain Res 817:199-205.
80. Meister A. 1995. Mitochondrial changes associated with glutathione deficiency. Biochim Biophys Acta 1271:35-42.
81. Meister A. 1994. Glutathione, ascorbate, and cellular protection. Cancer Res 54:1969s-1975s.
82. Michelet L, Zaffagnini M, Massot V, Keryer E, Vanacker H, Miginiac-Maslow M, Issakidis-Bourguet E, Lemaire SD. 2006. Thioredoxins, glutaredoxins, and glutathionylation:New crosstalks to explore. Photosynth Res 89:225-245.
83. Montine TJ, Quinn J, Kaye J, Morrow JD. 2007. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. J Mol Neurosci 33:114-119.
84. Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. 2002. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med 33:620-626.
85. Montine TJ, Beal MF, Robertson D, Cudkowicz ME, Biaggioni I, O'Donnell H, Zackert WE, Roberts LJ and Morrow JD. 1999. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology 52:1104-1105.
86. Moreira PI, Smith MA, Zhu X, Nunomura A, Castellani RJ, Perry G. 2005. Oxidative stress and neurodegeneration. Ann N Y Acad Sci 1043:545-552.
87. Newman SF, Sultana R, Perluigi M, Coccia R, Cai J, Pierce WM, Klein JB, Turner DM, Butterfield DA. 2007. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res 85:1506-1514.
88. Pan T, Jankovic J, Le W. 2003. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 20:711-721.
89. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. 2000. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3u-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol 59:357-367.
90. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F. 2003. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: A potential role in the pathogenesis of the disease. J Biol Chem 278:42588-42595.
91. Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, Butterfield DA. 2006a. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Neuroscience 138:1161-1170.
92. Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, Cini C, Butterfield DA. 2006b. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J Neurosci Res 84:418-426.
93. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, Lamas S. 2001. Glutathionylation of the p50 subunit of NF-kB: A mechanism for redox-induced inhibition of DNA binding. Biochemistry 40:14134-14142.
94. Polidori MC, Griffiths HR, Mariani E, Mecocci P. 2007. Hallmarks of protein oxidative damage in neurodegenerative diseases: Focus on Alzheimer's disease. Amino Acids 32:553-559.
95. Poon HF, Calabrese V, Calvani M, Butterfield DA. 2006. Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by l-acetylcarnitine: Insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. Antioxid Redox Signal 8:381-394.
96. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. 2002. Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Arch Neurol 59:972-976.
97. Pratico D, Trojanowski JQ, Rokach J, Fitzgerald GA. 1998. Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo. FASEB J 12:1777-1783.
98. Ravichandran V, Seres T, Moriguchi T, Thomas JA, Johnston RB, Jr. 1994. S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem 269:25010-25015.
99. Rebrin I, Bayne AC, Mockett RJ, Orr WC, Sohal RS. 2004. Free aminothiols, glutathione redox state and protein mixed disulphides in aging Drosophila melanogaster. Biochem J 382:131-136.
100. Roberts LJ, 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. 1998. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 273:13605-13612.
101. Sayre LM, Smith MA, Perry G. 2001. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8:721-738.
102. Scalbert A, Johnson IT, Saltmarsh M. 2005. Polyphenols: Antioxidants and beyond. Am J Clin Nutr 81:215S-217S.
103. Scapagnini G, Colombrita C, Amadio M, D'Agata V, Arcelli E, Sapienza M, Quattrone A, Calabrese V. 2006. Curcumin activates defensive genes and protects neurons against oxidative stress, Antioxid. Redox Signal 8:395-403.
104. Scapagnini G, Butterfield DA, Colombrita C, Sultana R, Pascale A, Calabrese V. 2004. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 6:811-818.
105. Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-4411.
106. Sen CK. 1998. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55:1747-1758.
107. Shackelford RE, Heinloth AN, Heard SC, Paules RS. 2005. Cellular and molecular targets of protein S-glutathiolation. Antioxid Redox Signal 7:940-950.
108. Shelton MD, Chock PB, Mieyal JJ. 2005. Glutaredoxin: Role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 7:348-366.
109. Smolka MB, Zhou H, Purkayastha S, Aebersold R. 2001. Optimization of the isotopecoded affinity tag-labeling procedure for quantitative proteome analysis. Anal Biochem 297:25-31.
110. Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santorelli FM, Piemonte F. 2006. Protein glutathionylation in human central nervous system:Potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res 83:256-263.
111. Sultana R, Newman SF, Abdul HM, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA. 2006a. Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: Redox proteomics study. J Neurosci Res 84:409-417.
112. Sultana R, Perluigi M, Butterfield DA. 2006b. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 8:2021-2037.
113. Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA. 2005. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J Neurochem 92:749-758.
114. Tilleman K, Stevens I, Spittaels K, Haute CV, Clerens S, Van Den Bergh G, Geerts H, Van Leuven F, Vandesande F, Moens L. 2002. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: A proteomics point of view. Proteomics 2:94-104.
115. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40.
116. Volpe A, Biasi D, Caramaschi P, Mantovani W, Bambara LM, Canestrini S, Ferrari M, Poli G, Degan M, Carletto A, Pieropan S, Minuz P. 2006. Levels of F2-isoprostanes in systemic sclerosis: Correlation with clinical features. Rheumatology (Oxford) 45:314-320.
117. Wagner Y, Sickmann A, Meyer HE, Daum G. 2003. Multidimensional nano-HPLC for analysis of protein complexes. J Am Soc Mass Spectrom 14:1003-1011.
118. Weinreb O, Amit T, Youdim MB. 2007. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. Free Radic Biol Med 43:546-556.
119. Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz O, Sanchez JC, Yan JX, Gooley AA, Hughes G, Humphery-Smith I, Williams KL, Hochstrasser DF. 1996. From proteins to proteomes: Large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 14:61-65.
120. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK. 2001. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133:89-96.
121. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. 2005 Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892-5901.
122. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. 2002. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 23:843-853.
123. Youdim KA, Spencer JP, Schroeter H, Rice-Evans C. 2002. Dietary flavonoids as potential neuroprotectants. Biol Chem 383:503-519.
124. Zhou H, Watts JD, Aebersold R. 2001. A systematic approach to the analysis of protein phosphorylation. Nat Biotechnol 19:375-378.